Search

Your search keyword '"Arias-Martínez, Joel"' showing total 10 results
Start Over Author "Arias-Martínez, Joel" Publication Year Range Last 10 years
10 results on '"Arias-Martínez, Joel"'

2. Energías alternativas renovables en México: el gran tema

Author

Vargas López, Juan Manuel, primary, Bautista Olivas, Ana Laura, additional, Álvarez Chávez, Clara Rosalía, additional, Romero Hidalgo, Jorge Alberto, additional, Taddei Bringas, Jorge Luis, additional, Olea Miranda, Jaime, additional, Isiordia Lachica, Paula Concepción, additional, Rodríguez Carvajal, Ricardo Alberto, additional, Esquer Peralta, Javier, additional, Munguía Vega, Nora Elba, additional, Velásquez Contreras, Luis Eduardo, additional, Almanza Sánchez, María, additional, Encinas Soto, Kareen Krizzan, additional, Mártin García, Abraham Rogelio, additional, Olivas Avendaño, Efraín, additional, Rodríguez Félix, Francisco, additional, López Ahumada, Guadalupe Amanda, additional, Rueda Puente, Édgar Omar, additional, Magar Brunner, Vanesa, additional, García Hernández, Luis Salvador, additional, Martinez Macias, Maria del Rosario, additional, Aguilar Ruiz, Rocio Janeth, additional, Arias Martínez, Joel, additional, Quintero Vargas, Jael Teresa de Jesús, additional, Uriarte Montoya, Mario Hiram, additional, Villegas Carrazco, César, additional, López Corona, Betzabe Ebenhezer, additional, Vargas Ramírez, Juan Manuel, additional, Mondaca Fernández, Iram, additional, Ruiz Leza, Héctor Arturo, additional, Sánchez Carmona, Arturo del Sagrado Corazón, additional, Valdez Vázquez, Idania, additional, Amaya Delgado, Lorena, additional, Buitrón Méndez, Germán, additional, Rodríguez Jasso, Rosa María, additional, Escalante Kantun, Nayeli Ariana, additional, Zamorano Escárcega, Gerardo, additional, and Heredia Olea, Erick, additional

Published
2021
Full Text
View/download PDF

7. Additional file 1: of Estimation of umbilical cord blood leptin and insulin based on anthropometric data by means of artificial neural network approach: identifying key maternal and neonatal factors

Author

Guzmán-Bárcenas, José, Hernández, José, Arias-Martínez, Joel, Baptista-González, Héctor, Ceballos-Reyes, Guillermo, and Irles, Claudine

Subjects
body regions, equipment and supplies
Abstract

Table S1. Weights and biases for the ANN perinatal model to predict UCB leptin concentration. Weights and biases for the network architecture performance of 12-5-1 for leptin ANN perinatal model. Table S2. Weights and biases for the ANN perinatal model to predict UCB insulin concentration. Weights and biases for the network architecture performance of 12-5-1 for insulin ANN perinatal model. Table S3. Weights and biases for the ANN prenatal model to predict UCB leptin concentration. Weights and biases for the network architecture performance of 6-5-1 for leptin ANN prenatal model. Table S4. Weights and biases for the ANN prenatal model to predict UCB insulin concentration. Weights and biases for the network architecture performance of 6-4-1 for insulin ANN prenatal model. (DOCX 60 kb)

Published
2016
Full Text
View/download PDF

10. Thromboembolic and hemorrhagic complications in patients with prosthetic heart valves cared for in a tertiary care center. What have we learned?

Author

Sánchez-Medina FF, Valenzuela-Antelo O, Valenzuela-Molina LC, Arias-Martínez J, López-Morales CM, and Ornelas-Aguirre JM

Subjects
Humans, Tertiary Care Centers, Anticoagulants therapeutic use, Hemorrhage epidemiology, Hemorrhage etiology, Heart Valves, Thromboembolism epidemiology, Thromboembolism etiology, Thromboembolism prevention & control, Heart Valve Prosthesis adverse effects, Heart Valve Prosthesis Implantation adverse effects
Abstract

Background: Heart valve replacement surgery with mechanical or biological prostheses entails a risk of thromboembolism and bleeding complications., Objective: To determine the complications related to complementary anticoagulation therapy and the probability of risk., Methods: One-hundred and sixty-three patients who underwent heart valve replacement between 2002 and 2016 with either mechanical or biological prostheses, and who received vitamin K antagonists after hospital discharge, were studied. Anticoagulation therapy was categorized into optimal and non-optimal according to INR values prior to the development of complications. Patients with comorbidities and other risk factors for thrombosis and/or bleeding were excluded., Results: In total, 68.7 % of patients received mechanical prostheses, and 31.3 %, biological prostheses (p ≤ 0.001); 25.2 % experienced the complications that motivated the study (p ≤ 0.001), which were hemorrhagic in 48.8 %, thromboembolic in 26.8 %, and of both types in 24.4 % (relative risk = 4.229). Among the patients with complications, 95.1 % received mechanical prostheses, and 4.9 %, biological (p = 0.005); non-optimal INR was identified in 49.7 % (p ≤ 0.001)., Conclusions: Given the high risk of thromboembolic and hemorrhagic complications, valve prostheses must be carefully chosen, and care priorities should include prevention and follow-up, especially in those patients who require anticoagulation therapy., (Copyright: © 2023 Permanyer.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results